[go: up one dir, main page]

PE20170763A1 - VBI STRAINS AND USES OF THE SAME - Google Patents

VBI STRAINS AND USES OF THE SAME

Info

Publication number
PE20170763A1
PE20170763A1 PE2016001848A PE2016001848A PE20170763A1 PE 20170763 A1 PE20170763 A1 PE 20170763A1 PE 2016001848 A PE2016001848 A PE 2016001848A PE 2016001848 A PE2016001848 A PE 2016001848A PE 20170763 A1 PE20170763 A1 PE 20170763A1
Authority
PE
Peru
Prior art keywords
strains
vbi
same
relates
infectious bronchitis
Prior art date
Application number
PE2016001848A
Other languages
Spanish (es)
Inventor
Jorge Luis Chacon
Zoltan Penzes
Zoltan Nagy
Anna Kollar
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of PE20170763A1 publication Critical patent/PE20170763A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invencion se relaciona con cepas novedosas del virus de la bronquitis infecciosa y los usos de las mismas. La invencion se relaciona mas particularmente con una cepa de VBI atenuado novedosa de genotipo BR-I, formas inactivadas de la misma, asi como con composiciones vacunales que comprenden dichas cepas. La invencion tambien se relaciona con acidos nucleicos, celulas infectadas y metodos para detectar las cepas del virus de la bronquitis infecciosa de la invencion en cualquier muestraThe present invention relates to novel strains of infectious bronchitis virus and the uses thereof. The invention more particularly relates to a novel attenuated IBV strain of the BR-I genotype, inactivated forms thereof, as well as to vaccine compositions comprising said strains. The invention also relates to nucleic acids, infected cells and methods for detecting the infectious bronchitis virus strains of the invention in any sample.

PE2016001848A 2015-09-30 2016-09-30 VBI STRAINS AND USES OF THE SAME PE20170763A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR102015025152A BR102015025152A8 (en) 2015-09-30 2015-09-30 infectious bronchitis virus, inactivated infectious bronchitis virus, nucleic acid, vector, polypeptide, vaccine, use of a strain of vbi, method for protecting poultry against infectious bronchitis virus, cell, method for preparing a vaccine, and method for detect vbi in a sample

Publications (1)

Publication Number Publication Date
PE20170763A1 true PE20170763A1 (en) 2017-07-04

Family

ID=58543698

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2016001848A PE20170763A1 (en) 2015-09-30 2016-09-30 VBI STRAINS AND USES OF THE SAME
PE2021001672A PE20212213A1 (en) 2015-09-30 2016-09-30 VBI STRAINS AND USES OF THE SAME

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2021001672A PE20212213A1 (en) 2015-09-30 2016-09-30 VBI STRAINS AND USES OF THE SAME

Country Status (3)

Country Link
AR (1) AR106207A1 (en)
BR (1) BR102015025152A8 (en)
PE (2) PE20170763A1 (en)

Also Published As

Publication number Publication date
BR102015025152A2 (en) 2017-04-04
BR102015025152A8 (en) 2021-08-10
AR106207A1 (en) 2017-12-20
PE20212213A1 (en) 2021-11-19

Similar Documents

Publication Publication Date Title
BR112018008078A2 (en) broad spectrum influenza virus vaccine
BR112018008090A2 (en) herpes simplex virus vaccine.
MX2015007755A (en) VACCINES AGAINST INFLUENZA VIRUSES AND ITS USES.
MX2018007198A (en) Human immunodeficiency virus antigens, vectors, compositions, and methods of use thereof.
CL2018001051A1 (en) Nucleic acid vaccines against varicella zoster virus (vzv)
BR112018008102A2 (en) respiratory syncytial virus vaccine
MX383596B (en) BISPECIFIC MOLECULES THAT ARE IMMUNOREEACTIVE WITH IMMUNE EFFECTOR CELLS THAT EXPRESS AN ACTIVATING RECEPTOR AND AN ANTIGEN EXPRESSED BY A VIRUS-INFECTED CELL AND THEIR USES.
CO2018006706A2 (en) Mutated viruses, method of preparation and use thereof
EA201691945A1 (en) ANTIBODIES TO HEMAGGLUTININ VIRUS OF TYPE B VIRUS AND METHODS OF THEIR APPLICATION
EA201391515A1 (en) INACTIVATED DENGE VIRUS VACCINE
MX2021010060A (en) Production of viruses in avian eggs.
MX2017011655A (en) AZA-PIRIDONA COMPOUNDS AND USES OF THESE.
MX2016016746A (en) Dual adjuvant vaccine compositions, preparation and uses.
DOP2018000209A (en) ALFAVIRUS CONSTRUCTOS ATENUADO VIVO AND METHODS AND USES OF THE SAME
MX2017016896A (en) Inactivated canine influenza vaccines and methods of making and uses thereof.
MX363464B (en) Influenza h5 vaccines.
CO7461135A2 (en) Porcine parvovirus 5b, methods of use and vaccine
CL2018000253A1 (en) Enhanced immune response of swine species
MX373809B (en) RECOMBINANT SWINEPOX VIRUS AND VACCINES.
EA201991319A1 (en) VACCINES OF ATTENUATED SWINE INFLUENZA AND METHODS OF THEIR MANUFACTURE AND APPLICATION
PE20170763A1 (en) VBI STRAINS AND USES OF THE SAME
AR095118A1 (en) A COMPOSITION VIRAL INACTIVATION PROCEDURE THAT INCLUDES FACTOR VII
WO2018175580A3 (en) Development of an alternative modified live influenza b virus vaccine
EA201892385A1 (en) MODIFICATION OF CONSTRUCTED POLYPEPTIDES OF THE HYMAGGLUTININ OF THE FLU VIRUS
MX2018006500A (en) LIVE VIRUS THAT HAS A BANK OF DAMAGED VIRUSES OF VIRUSES, AND A VACCINE AGAINST DENGUE THAT CONTAINS HIMSELF AS ANTIGENS.